As COVID-19 vaccine booster doses become available and individuals start considering getting a booster, questions may arise regarding current guidance, formulation of the booster doses, and potential risks, to name a few. How should clinicians answer these questions and more? In the slides below, find answers from the recently updated guidance from the US Centers for Disease Control and Prevention (CDC) on COVID-19 vaccine booster shots to help you prepare.
Yes. COVID-19 booster shots are the same formulation as the current COVID-19 vaccines. However, in the case of the Moderna COVID-19 vaccine booster shot, the dose is half of the amount of the vaccine people get for their primary series.
No. COVID-19 vaccines are working well to prevent severe illness, hospitalization, and death. However, public health experts are starting to see reduced protection over time against mild and moderate disease, especially among certain populations.
Adults and children may have some side effects from a COVID-19 vaccine, including pain, redness or swelling at the injection site, tiredness, headache, muscle pain, chills, fever and nausea. Serious side effects are rare but may occur.
Yes. Everyone is still considered fully vaccinated 2 weeks after their second dose in a 2-shot series (Pfizer or Moderna), or 2 weeks after a single-dose vaccine (ie, J&J).
Yes. Although COVID-19 vaccines remain effective in preventing severe disease, recent data suggest their effectiveness at preventing infection or severe illness wanes over time, especially in people aged ≥65 years.